These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21612933)

  • 61. Discovery of Membrane-Bound Pyrophosphatase Inhibitors Derived from an Isoxazole Fragment.
    Johansson NG; Turku A; Vidilaseris K; Dreano L; Khattab A; Ayuso Pérez D; Wilkinson A; Zhang Y; Tamminen M; Grazhdankin E; Kiriazis A; Fishwick CWG; Meri S; Yli-Kauhaluoma J; Goldman A; Boije Af Gennäs G; Xhaard H
    ACS Med Chem Lett; 2020 Apr; 11(4):605-610. PubMed ID: 32292570
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose T; Simmons A
    J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isoxazole Derivatives as Regulators of Immune Functions.
    Zimecki M; Bąchor U; Mączyński M
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30360408
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
    Hasenoehrl C; Storr M; Schicho R
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation.
    Gyires K; Zádori ZS
    Curr Neuropharmacol; 2016; 14(8):935-951. PubMed ID: 26935536
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ethyl 5-(4-amino-phen-yl)isoxazole-3-carboxyl-ate.
    Zhao JT; Qi JJ; Zhou YJ; Lv JG; Zhu J
    Acta Crystallogr Sect E Struct Rep Online; 2012 Apr; 68(Pt 4):o1111. PubMed ID: 22589968
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis and antimicrobial activity of N'-heteroarylidene-1-adamantylcarbohydrazides and (±)-2-(1-adamantyl)-4-acetyl-5-[5-(4-substituted phenyl-3-isoxazolyl)]-1,3,4-oxadiazolines.
    El-Emam AA; Alrashood KA; Al-Omar MA; Al-Tamimi AM
    Molecules; 2012 Mar; 17(3):3475-83. PubMed ID: 22426528
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Switching cannabinoid response from CB(2) agonists to FAAH inhibitors.
    Tourteau A; Leleu-Chavain N; Body-Malapel M; Andrzejak V; Barczyk A; Djouina M; Rigo B; Desreumaux P; Chavatte P; Millet R
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1322-6. PubMed ID: 24508127
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Design, synthesis and biological evaluation of potent FAAH inhibitors.
    Tuo W; Leleu-Chavain N; Barczyk A; Renault N; Lemaire L; Chavatte P; Millet R
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2701-5. PubMed ID: 27117424
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
    Morera L; Labar G; Ortar G; Lambert DM
    Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
    Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
    J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis.
    Andrzejak V; Muccioli GG; Body-Malapel M; El Bakali J; Djouina M; Renault N; Chavatte P; Desreumaux P; Lambert DM; Millet R
    Bioorg Med Chem; 2011 Jun; 19(12):3777-86. PubMed ID: 21612933
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
    Seierstad M; Breitenbucher JG
    J Med Chem; 2008 Dec; 51(23):7327-43. PubMed ID: 18983142
    [No Abstract]   [Full Text] [Related]  

  • 74. Insight into the medicinal chemistry of the endocannabinoid hydrolase inhibitors.
    Kapanda CN; Poupaert JH; Lambert DM
    Curr Med Chem; 2013; 20(14):1824-46. PubMed ID: 23410152
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.